Veltassa and Renal injury - a phase IV clinical study of FDA data

Summary:

Renal injury is reported as a side effect among people who take Veltassa (patiromer sorbitex calcium), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Nexium, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Renal injury when taking Veltassa. It is created by eHealthMe based on reports of 15,647 people who have side effects when taking Veltassa from the FDA, and is updated regularly.

What is Veltassa?

Veltassa has active ingredients of patiromer sorbitex calcium. eHealthMe is studying from 15,649 Veltassa users. Check the latest studies of Veltassa.

What is Renal injury?

Renal injury (kidney injury) is found to be associated with 1,204 drugs and 795 conditions by eHealthMe. Check the latest studies of Renal injury.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

15,647 people reported to have side effects when taking Veltassa.
Among them, 21 people (0.13%) have Renal injury.

Among these 21 people:

How long have people been on Veltassa when they have Renal injury? *

What is the gender of people who have Renal injury when taking Veltassa? *

female: 38.1 %
male: 61.9 %

What is the age of people who have Renal injury when taking Veltassa? *

What are other drugs people take besides Veltassa? *

What are other side effects people have besides Renal injury? *

Acute Kidney Failure: 14 people, 66.67%
Chronic Kidney Disease: 13 people, 61.90%
Renal Impairment (severely reduced kidney function): 4 people, 19.05%
Depression: 4 people, 19.05%
Hyperkalemia (damage to or disease of the kidney): 3 people, 14.29%
Urinary Tract Infection: 2 people, 9.52%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 9.52%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 1 person, 4.76%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 4.76%
Gait Disturbance: 1 person, 4.76%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 66.67%
High Blood Pressure: 9 people, 42.86%
High Blood Cholesterol: 8 people, 38.10%
Pain: 7 people, 33.33%
Hyperkalemia (damage to or disease of the kidney): 6 people, 28.57%
Muscle Spasms (muscle contraction): 4 people, 19.05%
Chest Pain: 4 people, 19.05%
Iron Deficiency: 4 people, 19.05%
Diabetes: 4 people, 19.05%
Depression: 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Veltassa and have Renal injury?

- Check whether Renal injury is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Veltassa:

Veltassa (15,649 reports)

Renal injury treatments and more:

Renal injury (61,065 reports)

Browse all side effects of Veltassa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Renal injury:

Renal injury (1,204 drugs)

Browse all the conditions that are associated with Renal injury:

Renal injury (795 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on patiromer sorbitex calcium (the active ingredients of Veltassa) and Veltassa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.